Skip to content
10-Q

Quarterly Report

COLLEGIUM PHARMACEUTICAL, INC COLL

0001104659-25-107391

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 31.61M sh
Shares Diluted Q3 2025 · Sep 30, 2025 39.44M sh
Shares Diluted Q3 2025 · Sep 30, 2025 39.39M sh
Shares Diluted Q3 2025 · Sep 30, 2024 40.16M sh
Shares Diluted Q3 2025 · Sep 30, 2024 40.4M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $25.1M
Stock Repurchased Q3 2025 · Sep 30, 2024 $35M
Capex Q3 2025 · Sep 30, 2025 $1.05M
Capex Q3 2025 · Sep 30, 2024 $1.08M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $206.28M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $120.34M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $150.1M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $70.57M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $38.96M
Stockholders Equity Q3 2025 · Sep 30, 2025 $274.81M
Stockholders Equity Q3 2025 · Jun 30, 2025 $232.21M
Stockholders Equity Q3 2025 · Mar 31, 2025 $234.43M
Stockholders Equity Q3 2025 · Dec 31, 2024 $228.84M
Stockholders Equity Q3 2025 · Sep 30, 2024 $234.28M
Stockholders Equity Q3 2025 · Jun 30, 2024 $216.58M
Stockholders Equity Q3 2025 · Mar 31, 2024 $222.17M
Stockholders Equity Q3 2025 · Dec 31, 2023 $195.43M
Current Liabilities Q3 2025 · Sep 30, 2025 $452.93M
Current Liabilities Q3 2025 · Dec 31, 2024 $509.51M
Total Liabilities Q3 2025 · Sep 30, 2025 $1.33B
Total Liabilities Q3 2025 · Dec 31, 2024 $1.43B
Current Assets Q3 2025 · Sep 30, 2025 $613.87M
Current Assets Q3 2025 · Dec 31, 2024 $482.26M
Total Assets Q3 2025 · Sep 30, 2025 $1.61B
Total Assets Q3 2025 · Dec 31, 2024 $1.66B
Eps Diluted Q3 2025 · Sep 30, 2025 $0.84
Eps Diluted Q3 2025 · Sep 30, 2025 $1.28
Eps Diluted Q3 2025 · Sep 30, 2024 $0.27
Eps Diluted Q3 2025 · Sep 30, 2024 $1.51
Eps Basic Q3 2025 · Sep 30, 2025 $1.00
Eps Basic Q3 2025 · Sep 30, 2025 $1.45
Eps Basic Q3 2025 · Sep 30, 2024 $0.29
Eps Basic Q3 2025 · Sep 30, 2024 $1.75
Sga Expense Q3 2025 · Sep 30, 2025 $67.1M
Sga Expense Q3 2025 · Sep 30, 2025 $217.16M
Sga Expense Q3 2025 · Sep 30, 2024 $61.96M
Sga Expense Q3 2025 · Sep 30, 2024 $147.27M
Net Income Q3 2025 · Sep 30, 2025 $31.51M
Net Income Q3 2025 · Sep 30, 2025 $45.91M
Net Income Q3 2025 · Jun 30, 2025 $11.98M
Net Income Q3 2025 · Mar 31, 2025 $2.42M
Net Income Q3 2025 · Sep 30, 2024 $9.34M
Net Income Q3 2025 · Sep 30, 2024 $56.65M
Net Income Q3 2025 · Jun 30, 2024 $19.61M
Net Income Q3 2025 · Mar 31, 2024 $27.71M
Operating Income Q3 2025 · Sep 30, 2025 $62.09M
Operating Income Q3 2025 · Sep 30, 2025 $118.88M
Operating Income Q3 2025 · Sep 30, 2024 $34.84M
Operating Income Q3 2025 · Sep 30, 2024 $131.78M
Gross Profit Q3 2025 · Sep 30, 2025 $129.17M
Gross Profit Q3 2025 · Sep 30, 2025 $334.88M
Gross Profit Q3 2025 · Sep 30, 2024 $96.79M
Gross Profit Q3 2025 · Sep 30, 2024 $279.06M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $80.19M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $240.24M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $62.51M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $170.44M
Revenue Q3 2025 · Sep 30, 2025 $209.36M
Revenue Q3 2025 · Sep 30, 2025 $575.12M
Revenue Q3 2025 · Sep 30, 2024 $159.3M
Revenue Q3 2025 · Sep 30, 2024 $449.5M